OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
Farzaneh Darbeheshti, Elham Zokaei, Yaser Mansoori, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Farzaneh Darbeheshti, Elham Zokaei, Yaser Mansoori, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Showing 25 citing articles:
Circular RNAs: New layer of complexity evading breast cancer heterogeneity
Alyaa Dawoud, Z Zakaria, Hannah Hisham Rashwan, et al.
Non-coding RNA Research (2022) Vol. 8, Iss. 1, pp. 60-74
Open Access | Times Cited: 41
Alyaa Dawoud, Z Zakaria, Hannah Hisham Rashwan, et al.
Non-coding RNA Research (2022) Vol. 8, Iss. 1, pp. 60-74
Open Access | Times Cited: 41
Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer
Jing Zhu, Qian Li, Zhongping Wu, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 1, pp. 262-276
Open Access | Times Cited: 10
Jing Zhu, Qian Li, Zhongping Wu, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 1, pp. 262-276
Open Access | Times Cited: 10
Circular RNAs as Potential Biomarkers in Breast Cancer
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan Pol, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 725-725
Open Access | Times Cited: 35
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan Pol, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 725-725
Open Access | Times Cited: 35
Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer
Cihat Erdoğan, İlknur Süer, Murat Kaya, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301995-e0301995
Open Access | Times Cited: 6
Cihat Erdoğan, İlknur Süer, Murat Kaya, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301995-e0301995
Open Access | Times Cited: 6
Circular RNAs: biology and clinical significance of breast cancer
Zhanwei Wang, Hao Deng, Jin Yao, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 859-874
Open Access | Times Cited: 15
Zhanwei Wang, Hao Deng, Jin Yao, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 859-874
Open Access | Times Cited: 15
Circular RNAs in and out of Cells: Therapeutic Usages of Circular RNAs
Mingyu Ju, Dayeon Kim, Geurim Son, et al.
Molecules and Cells (2023) Vol. 46, Iss. 1, pp. 33-40
Open Access | Times Cited: 14
Mingyu Ju, Dayeon Kim, Geurim Son, et al.
Molecules and Cells (2023) Vol. 46, Iss. 1, pp. 33-40
Open Access | Times Cited: 14
Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches
Paola Pastena, Hiran Perera, Alessandro Martinino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2559-2559
Open Access | Times Cited: 5
Paola Pastena, Hiran Perera, Alessandro Martinino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2559-2559
Open Access | Times Cited: 5
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks
Roozbeh Heidarzadehpilehrood, Maryam Pirhoushiaran, Malina Osman, et al.
Deleted Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Roozbeh Heidarzadehpilehrood, Maryam Pirhoushiaran, Malina Osman, et al.
Deleted Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer
Mandana Azari, Farbod Bahreini, Vladimir N. Uversky, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115459-115459
Closed Access | Times Cited: 11
Mandana Azari, Farbod Bahreini, Vladimir N. Uversky, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115459-115459
Closed Access | Times Cited: 11
miR-135b: A Key Role in Cancer Biology and Therapeutic Targets
Yingchun Shao, Shuangshuang Zhang, Yuxin Pan, et al.
Non-coding RNA Research (2025) Vol. 12, pp. 67-80
Open Access
Yingchun Shao, Shuangshuang Zhang, Yuxin Pan, et al.
Non-coding RNA Research (2025) Vol. 12, pp. 67-80
Open Access
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
Lixin Li, Y. Hao, Lei Dong, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Lixin Li, Y. Hao, Lei Dong, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
Ehsan Razeghian, Ria Margiana, Supat Chupradit, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 25
Ehsan Razeghian, Ria Margiana, Supat Chupradit, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 25
The therapeutic potential of circular RNA in triple-negative breast cancer
Aiqi Xu, Lewei Zhu, Chengcai Yao, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Aiqi Xu, Lewei Zhu, Chengcai Yao, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Evaluation of Circ_0000977-Mediated Regulatory Network in Breast Cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors
Farzaneh Darbeheshti, Yaser Mansoori, Ghasem Azizi‐Tabesh, et al.
Biochemical Genetics (2023) Vol. 61, Iss. 4, pp. 1487-1508
Closed Access | Times Cited: 8
Farzaneh Darbeheshti, Yaser Mansoori, Ghasem Azizi‐Tabesh, et al.
Biochemical Genetics (2023) Vol. 61, Iss. 4, pp. 1487-1508
Closed Access | Times Cited: 8
Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness
Farzaneh Darbeheshti, Sepideh Kadkhoda, Mahsa Keshavarz‐Fathi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Farzaneh Darbeheshti, Sepideh Kadkhoda, Mahsa Keshavarz‐Fathi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
Alina Catalina Palcau, R. Brandi, Nikolay Mehterov, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4181-4181
Open Access | Times Cited: 7
Alina Catalina Palcau, R. Brandi, Nikolay Mehterov, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4181-4181
Open Access | Times Cited: 7
Prospect of exosomal circular RNAs in breast Cancer: presents and future
Elham Zokaei, Farzaneh Darbeheshti, Nima Rezaei
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 6997-7011
Closed Access | Times Cited: 11
Elham Zokaei, Farzaneh Darbeheshti, Nima Rezaei
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 6997-7011
Closed Access | Times Cited: 11
Hsa_circ_0001925 promotes malignant progression in triple‐negative breast cancer via miR ‐1299/YY1 axis
Bin‐jie Shen, Yi‐fei Yang, Xiu‐xia Zhang
Thoracic Cancer (2023) Vol. 14, Iss. 8, pp. 746-757
Open Access | Times Cited: 5
Bin‐jie Shen, Yi‐fei Yang, Xiu‐xia Zhang
Thoracic Cancer (2023) Vol. 14, Iss. 8, pp. 746-757
Open Access | Times Cited: 5
Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC)
Amal Qattan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2624-2624
Open Access | Times Cited: 1
Amal Qattan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2624-2624
Open Access | Times Cited: 1
Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer
Nafiseh Tashakori, M. V. Mikhailova, Zainab Abbas Mohammedali, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155569-155569
Closed Access | Times Cited: 1
Nafiseh Tashakori, M. V. Mikhailova, Zainab Abbas Mohammedali, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155569-155569
Closed Access | Times Cited: 1
Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review
Zahra Foruzandeh, Davood Ghavi Dorabadi, Farzaneh Sadeghi, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9825-9840
Closed Access | Times Cited: 4
Zahra Foruzandeh, Davood Ghavi Dorabadi, Farzaneh Sadeghi, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9825-9840
Closed Access | Times Cited: 4
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications
Roman Beňačka, Daniela Szabóová, Zuzana Guľašová, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 127-127
Open Access
Roman Beňačka, Daniela Szabóová, Zuzana Guľašová, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 127-127
Open Access
Bioinformatics Analysis of the Potentially Functional circRNA-miRNA-mRNA Network in Breast Cancer
Cihat Erdoğan, İlknur Süer, Murat Kaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Cihat Erdoğan, İlknur Süer, Murat Kaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Interdisciplinary Approach in Breast Cancer
Farzaneh Darbeheshti, Nima Rezaei
(2022), pp. 1-11
Closed Access
Farzaneh Darbeheshti, Nima Rezaei
(2022), pp. 1-11
Closed Access
Hypoxia-Related Long Non-Coding RNA Signature Predicts the Prognosis of Breast Cancer
Jinlong Huo, Shuang Shen, Chen Chen, et al.
Research Square (Research Square) (2021)
Open Access
Jinlong Huo, Shuang Shen, Chen Chen, et al.
Research Square (Research Square) (2021)
Open Access
